Literature DB >> 16987437

GATA factors in vertebrate heart development and disease.

Alison Brewer1, John Pizzey.   

Abstract

Vertebrate heart formation is dependent upon complex hierarchical gene regulatory networks, which effect both the specification and differentiation of cardiomyocytes and subsequently cardiac morphogenesis. GATA-4, -5 and -6 comprise an evolutionarily conserved subfamily of transcription factors, which are expressed within the precardiac mesoderm from early stages in its specification and continue to be expressed within the adult heart. We review here the functional roles of individual GATA transcription factors in cardiac development, normal homeostasis and disease. We also review the cellular mechanisms employed to regulate the expression and downstream targets of the different GATA factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987437     DOI: 10.1017/S1462399406000093

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  22 in total

1.  Wnt/beta-catenin signalling regulates cardiomyogenesis via GATA transcription factors.

Authors:  Jennifer Martin; Boni A Afouda; Stefan Hoppler
Journal:  J Anat       Date:  2010-01       Impact factor: 2.610

2.  A novel GATA4 loss-of-function mutation associated with congenital ventricular septal defect.

Authors:  Yi-Qing Yang; Li Li; Juan Wang; Xing-Yuan Liu; Xiao-Zhong Chen; Wei Zhang; Xiao-Zhou Wang; Jin-Qi Jiang; Xu Liu; Wei-Yi Fang
Journal:  Pediatr Cardiol       Date:  2011-11-20       Impact factor: 1.655

3.  Loss of intestinal GATA4 prevents diet-induced obesity and promotes insulin sensitivity in mice.

Authors:  Jay V Patankar; Prakash G Chandak; Sascha Obrowsky; Thomas Pfeifer; Clemens Diwoky; Andreas Uellen; Wolfgang Sattler; Rudolf Stollberger; Gerald Hoefler; Akos Heinemann; Michele Battle; Stephen Duncan; Dagmar Kratky; Sanja Levak-Frank
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-12-21       Impact factor: 4.310

Review 4.  Endothelin-1 gene regulation.

Authors:  Lisa R Stow; Mollie E Jacobs; Charles S Wingo; Brian D Cain
Journal:  FASEB J       Date:  2010-09-13       Impact factor: 5.191

5.  Mutation spectrum of the GATA4 gene in patients with idiopathic atrial fibrillation.

Authors:  Jun Wang; Yu-Min Sun; Yi-Qing Yang
Journal:  Mol Biol Rep       Date:  2012-05-03       Impact factor: 2.316

6.  Induction of interleukin-6 expression by bone morphogenetic protein-6 in macrophages requires both SMAD and p38 signaling pathways.

Authors:  Geun Taek Lee; Seok Joo Kwon; Jae-Ho Lee; Seong Soo Jeon; Kee Taek Jang; Han Yong Choi; Hyun Moo Lee; Wun-Jae Kim; Seong Jin Kim; Isaac Yi Kim
Journal:  J Biol Chem       Date:  2010-10-01       Impact factor: 5.157

7.  Pancreas-specific deletion of mouse Gata4 and Gata6 causes pancreatic agenesis.

Authors:  Shouhong Xuan; Matthew J Borok; Kimberly J Decker; Michele A Battle; Stephen A Duncan; Michael A Hale; Raymond J Macdonald; Lori Sussel
Journal:  J Clin Invest       Date:  2012-09-24       Impact factor: 14.808

8.  CUG-BP, Elav-like family member 1 (CELF1) is required for normal myofibrillogenesis, morphogenesis, and contractile function in the embryonic heart.

Authors:  Yotam Blech-Hermoni; Connor B Sullivan; Michael W Jenkins; Oliver Wessely; Andrea N Ladd
Journal:  Dev Dyn       Date:  2016-05-31       Impact factor: 3.780

9.  Cell fate decisions are specified by the dynamic ERK interactome.

Authors:  Daniela Baiocchi; Marc Birtwistle; Alex von Kriegsheim; David Sumpton; Willy Bienvenut; Nicholas Morrice; Kayo Yamada; Angus Lamond; Gabriella Kalna; Richard Orton; David Gilbert; Walter Kolch
Journal:  Nat Cell Biol       Date:  2009-11-22       Impact factor: 28.824

10.  Long non-coding RNAs link extracellular matrix gene expression to ischemic cardiomyopathy.

Authors:  Zhan-Peng Huang; Yan Ding; Jinghai Chen; Gengze Wu; Masaharu Kataoka; Yongwu Hu; Jian-Hua Yang; Jianming Liu; Stavros G Drakos; Craig H Selzman; Jan Kyselovic; Liang-Hu Qu; Cristobal G Dos Remedios; William T Pu; Da-Zhi Wang
Journal:  Cardiovasc Res       Date:  2016-11-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.